Chen Xiaoshan, Chen Xiaolin, Zhao Xinming, Pang Xiao, Dai Meng, Sun Yuhan, Wang Mengjiao, Han Jingya, Zhao Yan
Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, Hebei, 050011, China.
Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Shijiazhuang, Hebei, 050011, China.
Eur J Nucl Med Mol Imaging. 2025 Apr 24. doi: 10.1007/s00259-025-07296-x.
This study aimed to investigate the impact of glucose metabolism in subcutaneous adipose tissue (SAT) and skeletal muscle (SM) variables on overall survival (OS) in patients with locally advanced gastric cancer.
A retrospective study was conducted on 110 patients with advanced gastric cancer who underwent baseline [F]FDG PET/CT. Demographic, clinical, and survival data were collected. Mean standardized uptake value (SUVmean) of SAT as well as skeletal muscle, and body composition measurement, including SAT area, SAT radiodensity, SM area, and SM radiodensity, were assessed on PET/CT. SM area was normalized for patient stature, resulting in the skeletal muscle index (SMI). Patients were stratified into subgroups with high and low SAT uptake based on the optimum cut-off value of the SAT SUVmean. The univariate, multivariate regression analysis, Kaplan-Meier survival analysis, and Spearman's correlation analysis were employed to evaluate the associations among metabolic activity and CT-derived body composition variables as well as OS.
Out of 110 patients with an average age of 62.65 ± 13.25 years, 58 (52.73%) patients died during follow-up. Cox regression analysis identified TNM stage, SAT SUVmean, and SMI as independent prognostic factors for OS (all p < 0.05). Notably, patients with elevated SAT uptake exhibited significantly poorer long-term survival compared to those with low SAT uptake (p < 0.001). Correlation analyses revealed a moderate positive association between SAT SUVmean and SAT radiodensity (p < 0.001, r = 0.47), whereas a significant inverse correlation was observed between SAT SUVmean and SAT area (p < 0.001, r = -0.465). Additionally, stratification by combined SAT SUVmean and SMI profiles showed that patients with low SAT uptake and high SMI exhibited a better prognosis than those with high SAT uptake and/or low SMI (p = 0.004 and p < 0.001).
Increased [F]FDG uptake in SAT was correlated with higher SAT radiodensity as well as lower SAT area, and shortened survival in patients with advanced gastric cancer, underscoring its potential as a biomarker for adverse outcomes.
本研究旨在探讨皮下脂肪组织(SAT)和骨骼肌(SM)中的葡萄糖代谢变量对局部晚期胃癌患者总生存期(OS)的影响。
对110例行基线[F]FDG PET/CT检查的晚期胃癌患者进行回顾性研究。收集人口统计学、临床和生存数据。在PET/CT上评估SAT以及骨骼肌的平均标准化摄取值(SUVmean),并测量身体成分,包括SAT面积、SAT放射性密度、SM面积和SM放射性密度。将SM面积根据患者身高进行标准化,得出骨骼肌指数(SMI)。根据SAT SUVmean的最佳临界值将患者分为SAT摄取高和低的亚组。采用单因素、多因素回归分析、Kaplan-Meier生存分析和Spearman相关性分析来评估代谢活性与CT衍生的身体成分变量以及OS之间的关联。
110例患者平均年龄为62.65±13.25岁,其中58例(52.73%)患者在随访期间死亡。Cox回归分析确定TNM分期、SAT SUVmean和SMI为OS的独立预后因素(均p<0.05)。值得注意的是,SAT摄取升高的患者与SAT摄取低的患者相比,长期生存率显著较差(p<0.001)。相关性分析显示SAT SUVmean与SAT放射性密度之间存在中度正相关(p<0.001,r = 0.47),而SAT SUVmean与SAT面积之间存在显著负相关(p<0.001,r = -0.465)。此外,根据SAT SUVmean和SMI联合特征进行分层显示,SAT摄取低且SMI高的患者比SAT摄取高和/或SMI低的患者预后更好(p = 0.004和p<0.001)。
SAT中[F]FDG摄取增加与SAT放射性密度升高以及SAT面积降低相关,且与晚期胃癌患者的生存期缩短相关,这突出了其作为不良预后生物标志物的潜力。